To include your compound in the COVID-19 Resource Center, submit it here.

Siolta: Seeding the microbiome

How Siolta’s bacterial cocktail could prevent the onset of asthma in infants

Backed by Khosla Ventures and about a decade of research connecting the microbiome to allergic diseases, Siolta Therapeutics Inc. has its bacterial cocktail in a Phase I trial to prevent the onset of asthma in newborns along with a companion diagnostic for the disease.

Siolta co-founders Susan Lynch and Nikole Kimes met when Kimes joined Lynch’s lab as a postdoc at University of California San Francisco, where Lynch is an

Read the full 699 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers